Dr. Anne-Sophie Bonte has been appointed as the new Chief Quality Officer (CQO) and a member of the executive leadership team at contract developer and manufacturer Aenova.
 
In her role at Aenova, Anne-Sophie Bonte is responsible for the overall leadership, alignment and execution of the quality manufacturing programs, project management and quality processes across Aenova’s production sites and corporate.
 
“I am delighted to shape the further development of Aenova and set the strategic direction to enhance quality-manufacturing strategies, and effectively manage the associated activities and resources necessary to support and harmonize the organization’s quality aspects and business needs,” Bonte remarked.
 
Bonte has years of experience in quality management in the pharmaceutical industry and the CDMO environment. She held positions with companies like LFB, Roche and Cenexi before moving into high-level management positions at Catalent and Galderma.
 
She holds a PhD in Pharmacy and a Master’s degree in Biological and Medical Sciences from the University of Lille as well as an MSc in Pharmaceutical Development and Industrial Production of Health Products from the Industrial Institute of Pharmacy in Bordeaux.